2026年6月5日，锦欣生殖医疗集团有限公司（股票代码：01951）披露翌日披露报表，公告显示公司于当日在香港联交所场内回购414.00万股普通股，约占已发行股本的0.15%。本次回购每股价格介乎港元2.25至2.28，总金额约为938.21万港元。
本次回购完成后，公司已发行股本仍维持在2,705,044,043股，截至公告日并无库藏股。该回购授权决议于2025年6月26日通过，授权总额为2.74亿余股，已回购9,448.30万股，剩余回购额度约为1.80亿股。公司确认上述回购活动符合香港联交所证券上市规则及相关法例的规定。
上述公告由公司董事董阳签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.